Found: 5
Select item for more details and to access through your institution.
Rare naturally occurring immune responses to three epitopes from the widely expressed tumour antigens hTERT and CYP1B1 in multiple myeloma patients.
- Published in:
- Clinical & Experimental Immunology, 2005, v. 141, n. 3, p. 558, doi. 10.1111/j.1365-2249.2005.02879.x
- By:
- Publication type:
- Article
Tumour immunotherapy: new tools, new treatment modalities and new T-cell antigens.
- Published in:
- Vox Sanguinis, 2001, v. 80, n. 2, p. 81, doi. 10.1046/j.1423-0410.2001.00014.x
- By:
- Publication type:
- Article
Biological characterization of CD40-activated B cells as a prerequisite for their use as cellular adjuvant in cancer vaccines.
- Published in:
- Cancer Cell International, 2004, v. 4, p. S49, doi. 10.1186/1475-2867-4-S1-S49
- By:
- Publication type:
- Article
CD40-activated B cells can be generated in high number and purity in cancer patients: analysis of immunogenicity and homing potential.
- Published in:
- Clinical & Experimental Immunology, 2009, v. 155, n. 2, p. 249, doi. 10.1111/j.1365-2249.2008.03820.x
- By:
- Publication type:
- Article
Identification of native, immunogenic peptides from Cyclin D1.
- Published in:
- 2010
- By:
- Publication type:
- Letter